Main Article Content
The prevalence of diabetes and its associated complications have continued to increase globally. Tight glycemic control has been one of the effective ways towards the management of diabetes and its complications. This study was conducted to investigate independent predictors of glycemic levels among patients with diabetes attending a diabetic clinic of a tertiary health care facility. More than half (54.2%) of the 216 participants had good glycemic control. Participants with Body Mass Index (BMI) more than 25 had 79% lower odds of having controlled glycemic levels (95% CI; 0.095, 0.479), compared to those with BMI$<=25. Patients on combination therapy have a significantly higher odds of having good glycemic control compared to those on monotherapy [AOR 3.43 (1.615, 7.302)]. Other identified significant predictors of glycemic control include multiple complications, retinopathy, ethnicity, and self-reported physical activity (p<0.05). Our findings demonstrated that ethnicity, BMI, physical activity, retinopathy, and having more than one complication were independently associated with good glycemic control levels.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Submission of any work for publication in this journal would imply that the authors acknowledge that the work is their own and that they have taken all necessary permissions for all the materials used in their work.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors permit us for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Adeloye D, Ige JO, Aderemi AV, Adeleye N, Amoo EO, Auta A, et al. 2017. Estimating the prevalence, hospitalisation and mortality from type 2 diabetes mellitus in nigeria: A systematic review and meta-analysis. BMJ open 7:e015424.
Ahmad NS, Islahudin F, Paraidathathu T. 2014. Factors associated with good glycemic control among patients with type 2 diabetes mellitus. Journal of Diabetes Investigation 5:563-569.
American Diabetes A. 2009. Diagnosis and classification of diabetes mellitus. Diabetes care 32 Suppl 1:S62-S67.
Arai K, Hirao K, Matsuba I, Takai M, Matoba K, Takeda H, et al. 2009. The status of glycemic control by general practitioners and specialists for diabetes in japan: A cross-sectional survey of 15,652 patients with diabetes mellitus. Diabetes research and clinical practice 83:397-401.
Atlas D. 2015. International diabetes federation. IDF Diabetes Atlas, 7th edn Brussels, Belgium: International Diabetes Federation.
Bell D. 2013. Combine and conquer: Advantages and disadvantages of fixedâ€dose combination therapy. Diabetes, Obesity and Metabolism 15:291-300.
Beran D, Yudkin JS. 2006. Diabetes care in sub-saharan africa. Lancet (London, England) 368:1689-1695.
Cavaiola TS, Pettus JH. 2017. Management of type 2 diabetes: Selecting amongst available pharmacological agents.
Control D, Group CTR. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England journal of medicine 329:977-986.
Essien O, Otu A, Umoh V, Enang O, Hicks JP, Walley J. 2017. Intensive patient education improves glycaemic control in diabetes compared to conventional education: A randomised controlled trial in a nigerian tertiary care hospital. PloS one 12:e0168835.
Fiseha T, Alemayehu E, Kassahun W, Adamu A, Gebreweld A. 2018. Factors associated with glycemic control among diabetic adult out-patients in northeast ethiopia. BMC research notes 11:316.
Gearing RE, Mian IA, Barber J, Ickowicz A. 2006. A methodology for conducting retrospective chart review research in child and adolescent psychiatry. Journal of the Canadian Academy of Child and Adolescent Psychiatry 15:126.
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. 2014. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes research and clinical practice 103:137-149.
Haas L, Maryniuk M, Beck J, Cox CE, Duker P, Edwards L, et al. 2012. National standards for diabetes self-management education and support. The Diabetes Educator 38:619-629.
Kibirige D, Akabwai GP, Kampiire L, Kiggundu DS, Lumu W. 2017. Frequency and predictors of suboptimal glycemic control in an african diabetic population. International journal of general medicine 10:33-38.
Laotaveerungrueng N, Wanthong S, Wannachalee T, Lertwattanarak R. 2018. Prevalence of chronic microvascular complications and diabetic foot problems in patients with diabetes mellitus at siriraj hospital. Journal of the medical association of thailand 101:1349-1355.
Lawlor DA, Benfield L, Logue J, Tilling K, Howe LD, Fraser A, et al. 2010. Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: Prospective cohort study. Bmj 341:c6224.
LeRoith D, Smith DO. 2005. Monitoring glycemic control: The cornerstone of diabetes care. Clinical therapeutics 27:1489-1499.
Li J, Chattopadhyay K, Xu M, Chen Y, Hu F, Chu J, et al. 2018. Glycaemic control in type 2 diabetes patients and its predictors: A retrospective database study at a tertiary care diabetes centre in ningbo, china. BMJ open 8:e019697.
Lloyd A, Sawyer W, Hopkinson P. 2001. Impact of longâ€term complications on quality of life in patients with type 2 diabetes not using insulin. Value in Health 4:392-400.
Morales-Alvarez MC, Garcia-Dolagaray G, Millan-Fierro A, Rosas SE. 2019. Renal function decline in latinos with type 2 diabetes. Kidney International Reports.
Nigerian National Population Commission. 2006. National population commission nigeria 2006 census result. Nigeria.
Ogbera AO, Ekpebegh C. 2014. Diabetes mellitus in nigeria: The past, present and future. World journal of diabetes 5:905-911.
Osuji NA, Ojo OS, Malomo SO, Sogunle PT, Egunjobi AO, Odebunmi OO. 2018. Relationship between glycemic control and perceived family support among people with type 2 diabetes mellitus seen in a rich kinship network in southwest nigeria. Family Medicine and Community Health 6:168-177.
Rathmann W, Giani G. 2004. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes care 27:2568-2569; author reply 2569.
Reisig V, Reitmeir P, DÃ¶ring A, Rathmann W, Mielck A, Group KS. 2007. Social inequalities and outcomes in type 2 diabetes in the german region of augsburg. A cross-sectional survey. International Journal of Public Health 52:158-165.
Sekar V, Mani S, Malarvizhi R, Nithya P, Vasanthi HR. 2019. Antidiabetic effect of mangiferin in combination with oral hypoglycemic agents metformin and gliclazide. Phytomedicine 59:152901.
Sobngwi E, Ndour-Mbaye M, Boateng KA, Ramaiya KL, Njenga EW, Diop SN, et al. 2012. Type 2 diabetes control and complications in specialised diabetes care centres of six sub-saharan african countries: The diabcare africa study. Diabetes research and clinical practice 95:30-36.
Steinberger J, Jacobs Jr DR, Raatz S, Moran A, Hong C, Sinaiko AR. 2005. Comparison of body fatness measurements by bmi and skinfolds vs dual energy x-ray absorptiometry and their relation to cardiovascular risk factors in adolescents. International journal of obesity 29:1346.
Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al. 2000. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (ukpds 35): Prospective observational study. Bmj 321:405-412.
Ufuoma C, Godwin YD, Kester AD, Ngozi JC. 2016. Determinants of glycemic control among persons with type 2 diabetes mellitus in niger delta. Sahel Medical Journal 19:190.
UK Prospective Diabetes Study Group. 1998. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (ukpds 33). The lancet 352:837-853.
Valentine WJ, Palmer AJ, Nicklasson L, Cobden D, Roze S. 2006. Improving life expectancy and decreasing the incidence of complications associated with type 2 diabetes: A modelling study of hba1c targets. International journal of clinical practice 60:1138-1145.
WHO. 2006. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia : Report of a who/idf consultation.:WHO; IDF.
WHO. 2016. World health organisation. Global report on diabetes. Geneva 27, Switzerland:WHO.
Williams R. 2016. Estimating the national and global costs of diabetes. Diabetes research and clinical practice 119:118-120.
Worster A, Haines T. 2004. Advanced statistics: Understanding medical record review (mrr) studies. Academic Emergency Medicine 11:187-192.
Zimmet P, Alberti KGMM, Shaw J. 2001. Global and societal implications of the diabetes epidemic. Nature 414:782-787.